S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Top 5 Tech Stocks to Buy for 2024 (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Biden out June 13; Kamala won’t replace him? (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Top 5 Tech Stocks to Buy for 2024 (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Biden out June 13; Kamala won’t replace him? (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Top 5 Tech Stocks to Buy for 2024 (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Biden out June 13; Kamala won’t replace him? (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Top 5 Tech Stocks to Buy for 2024 (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Biden out June 13; Kamala won’t replace him? (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
Free Trial

Encompass Health (EHC) Earnings Date, Estimates & Call Transcripts

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free ehc Stock Alerts
$79.71
-0.26 (-0.33%)
(As of 04/17/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Apr. 24
After Market Closes
Confirmed
Actual EPS
(Feb. 7)
$0.95 Beat By $0.12
Consensus EPS
(Feb. 7)
$0.83
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

EHC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EHC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Encompass Health Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242$0.91$0.91$0.91 
Q2 20242$0.97$0.99$0.98 
Q3 20242$0.94$1.06$1.00 
Q4 20242$0.98$1.03$1.01 
FY 20248$3.80$3.99$3.90 
Q1 20252$1.03$1.07$1.05 
Q2 20252$1.09$1.12$1.11 
Q3 20252$1.05$1.09$1.07 
Q4 20252$1.15$1.19$1.17 
FY 20258$4.32$4.47 $4.40

EHC Earnings Date and Information

Encompass Health last posted its earnings data on February 7th, 2024. The reported $0.95 EPS for the quarter, topping the consensus estimate of $0.83 by $0.12. The firm had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.24 billion. Encompass Health has generated $3.47 earnings per share over the last year ($3.47 diluted earnings per share) and currently has a price-to-earnings ratio of 23.0. Earnings for Encompass Health are expected to grow by 11.36% in the coming year, from $3.96 to $4.41 per share. Encompass Health has confirmed that its next quarterly earnings report will be published on Wednesday, April 24th, 2024. Encompass Health will be holding an earnings conference call on Thursday, April 25th at 10:00 AM Eastern. Interested parties can register for or listen to the call..

Encompass Health Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/24/2024
Confirmed)		-------  
2/7/2024Q4 2023$0.83$0.95+$0.12$1.04$1.24 billion$1.25 billion
10/27/2023Q3 2023$0.77$0.86+$0.09$0.88$1.19 billion$1.21 billion      
8/1/2023Q2 2023$0.74$0.95+$0.21$1.00$1.16 billion$1.19 billion      
4/28/2023Q1 2023$0.70$0.88+$0.18$0.89$1.14 billion$1.16 billion      
2/7/2023Q4 2022$0.85$0.88+$0.03$0.87$1.12 billion$1.14 billion
10/26/2022Q3 2022$0.68$0.67($0.01)$0.89$1.06 billion$1.09 billion
8/1/2022Q2 2022$0.97$0.89($0.08)$1.29$1.34 billion$1.33 billion      
4/27/2022Q1 2022$0.93$0.97+$0.04$1.07$1.32 billion$1.33 billion      
2/1/2022Q4 2021$1.06$0.97($0.09)$1.03$1.31 billion$11.32 billion    
10/27/2021Q3 2021$1.06$1.03($0.03)$1.06$1.31 billion$1.28 billion    
7/26/2021Q2 2021$0.98$1.17+$0.19$1.21$1.28 billion$1.29 billion    
4/27/2021Q1 2021$0.80$1.05+$0.25$1.03$1.23 billion$1.23 billion
4/27/2021Q1 2021$0.82$1.05+$0.23$1.03$1.23 billion$1.23 billion  

Encompass Health Earnings - Frequently Asked Questions

When is Encompass Health's earnings date?

Encompass Health has confirmed that its next quarterly earnings data will be published on Wednesday, April 24th, 2024. Learn more on EHC's earnings history.

Did Encompass Health beat their earnings estimates last quarter?

In the previous quarter, Encompass Health (NYSE:EHC) reported $0.95 earnings per share (EPS) to beat the analysts' consensus estimate of $0.83 by $0.12. Learn more on analysts' earnings estimate vs. EHC's actual earnings.

How much revenue does Encompass Health generate each year?

Encompass Health (NYSE:EHC) has a recorded annual revenue of $4.80 billion.

How much profit does Encompass Health generate each year?

Encompass Health (NYSE:EHC) has a recorded net income of $352 million. EHC has generated $3.47 earnings per share over the last four quarters.

What is Encompass Health's price-to-earnings ratio?

Encompass Health (NYSE:EHC) has a trailing price-to-earnings ratio of 22.97 and a forward price-to-earnings ratio of 20.13. The price/earnings-to-growth ratio is 1.5.

What is Encompass Health's EPS forecast for next year?

Encompass Health's earnings are expected to grow from $3.96 per share to $4.41 per share in the next year, which is a 11.36% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NYSE:EHC) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
He Is Giving Away Bitcoin
Crypto Swap Profits
The “Perfect Storm” for Gold
Gold Safe Exchange
Urgent alert: open this for a huge profit potential
Timothy Sykes
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Top 5 Tech Stocks to Buy for 2024
Daily Market Alerts
Biden out June 13; Kamala won’t replace him?
Paradigm Press
The #1 Crypto for 2024
InvestorPlace